{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:56:24Z","timestamp":1788260184755,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2870,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.bbmt.2007.02.003","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T08:54:55Z","timestamp":1180083295000},"page":"701-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Sirolimus as Part of Immunosuppressive Therapy for Refractory Chronic Graft-versus-Host Disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Manuel","family":"Jurado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"P\u00e9rez-Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salut","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Ferra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Balsalobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"P\u00e9rez-Oteyza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildefonso","family":"Espigado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.02.003_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-126-3-199702010-00002","article-title":"Health and functional status of long-term survivors of bone marrow transplantation","volume":"126","author":"Duell","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.02.003_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"Socie","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.02.003_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood.V100.1.48","article-title":"Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone","volume":"100","author":"Koc","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.02.003_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V72.2.555.555","article-title":"Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease","volume":"72","author":"Sullivan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.02.003_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2005.01.011","article-title":"Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease","volume":"11","author":"Lopez","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.02.003_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00007890-200202270-00035","article-title":"Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease","volume":"27","author":"Chiang","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.02.003_bib7","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/blood.V86.9.3604.bloodjournal8693604","article-title":"Thalidomide as salvage therapy for chronic graft-versus-host disease","volume":"86","author":"Parker","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.02.003_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/blood.V93.1.66","article-title":"Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease","volume":"93","author":"Marcellus","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.02.003_bib9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2002-11-3351","article-title":"Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response","volume":"102","author":"Seaton","year":"2003","journal-title":"Blood"},{"issue":"3 suppl","key":"10.1016\/j.bbmt.2007.02.003_bib10","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S0041-1345(03)00230-6","article-title":"Molecular actions of sirolimus: sirolimus and mTor","volume":"35","author":"Kirken","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2007.02.003_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00007890-200008270-00027","article-title":"Mechanism of the combination of immunosupressive effects of sirolimus with either cyclosporine or tacrolimus","volume":"70","author":"Khanna","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.02.003_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(99)03882-9","article-title":"Sirolimus-tacrolimus combination immunosuppression","volume":"355","author":"McAlister","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2007.02.003_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.TP.0000074360.62032.39","article-title":"Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study","volume":"76","author":"Oberbauer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.02.003_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.intimp.2004.09.008","article-title":"Decreased cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients","volume":"5","author":"Ozaki","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bbmt.2007.02.003_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/01.TP.0000142127.84497.50","article-title":"BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression","volume":"78","author":"Wali","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.02.003_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cncr.20026","article-title":"Mammalian target of rapamycin inhibition as therapy for hematologic malignancies","volume":"100","author":"Panwalkar","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2007.02.003_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as GVHD prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.02.003_bib18","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (Rapamycin) for the treatment of acute GVHD refractory to first line therapy with steroids","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.02.003_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2005.05616.x","article-title":"Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease","volume":"130","author":"Couriel","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.02.003_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbmt.2004.10.004","article-title":"Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease","volume":"11","author":"Johnston","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.02.003_bib21","series-title":"Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment","first-page":"587","article-title":"Pathology of chronic graft-vs.-host disease","author":"Shulman","year":"1990"},{"key":"10.1016\/j.bbmt.2007.02.003_bib22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","article-title":"Antileukemic effect of chronic graft-versus-host disease","volume":"304","author":"Weiden","year":"1981","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2007.02.003_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03165081","article-title":"Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation","volume":"76","author":"Sanders","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2007.02.003_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.02.003_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood-2002-10-3141","article-title":"Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study","volume":"102","author":"Akpek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.02.003_bib26","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2004-01-0200","article-title":"Duration of immunosuppressive treatment for chronic graft-versus-host disease","volume":"104","author":"Stewart","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.02.003_bib27","first-page":"258","article-title":"Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome","volume":"91","author":"Skert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.02.003_bib28","doi-asserted-by":"crossref","first-page":"23166","DOI":"10.1074\/jbc.M401238200","article-title":"Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway","volume":"279","author":"Shegogue","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbmt.2007.02.003_bib29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2007.02.003_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.02.003_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbmt.2006.03.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI","volume":"12","author":"Martin","year":"2006","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107001474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107001474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:29:59Z","timestamp":1761056999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1083879107001474"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.02.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus as Part of Immunosuppressive Therapy for Refractory Chronic Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}